Although TIF1γ autoantibodies have been strongly associated with malignancy in dermatomyositis, none of the 60 patients with lung cancer tested positive for anti-TIF1, anti-NXP2 or anti-RNAP III autoantibodies (by either IP or TIF1γ ELISA), indicating that these autoantibodies are rare in patients with lung cancer without an autoimmune disease. Here, TRIM24 is linked to lung carcinoma.